BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27336295)

  • 1. (18)F- and (68)Ga-Labeled Neurotensin Peptides for PET Imaging of Neurotensin Receptor 1.
    Maschauer S; Einsiedel J; Hübner H; Gmeiner P; Prante O
    J Med Chem; 2016 Jul; 59(13):6480-92. PubMed ID: 27336295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved radiosynthesis and preliminary in vivo evaluation of a (18)F-labeled glycopeptide-peptoid hybrid for PET imaging of neurotensin receptor 2.
    Maschauer S; Greff C; Einsiedel J; Ott J; Tripal P; Hübner H; Gmeiner P; Prante O
    Bioorg Med Chem; 2015 Jul; 23(14):4026-33. PubMed ID: 25691211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel DOTA-neurotensin analogues for 111In scintigraphy and 68Ga PET imaging of neurotensin receptor-positive tumors.
    Alshoukr F; Prignon A; Brans L; Jallane A; Mendes S; Talbot JN; Tourwé D; Barbet J; Gruaz-Guyon A
    Bioconjug Chem; 2011 Jul; 22(7):1374-85. PubMed ID: 21662976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical PET Imaging of NTSR-1-Positive Tumors with
    Li D; Minnix M; Allen R; Bading J; Chea J; Wong P; Bowles N; Poku E; Shively JE
    Cancer Biother Radiopharm; 2021 Oct; 36(8):651-661. PubMed ID: 32822229
    [No Abstract]   [Full Text] [Related]  

  • 5. Facile Preparation of a Thiol-Reactive (18)F-Labeling Agent and Synthesis of (18)F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor.
    Wu Z; Li L; Liu S; Yakushijin F; Yakushijin K; Horne D; Conti PS; Li Z; Kandeel F; Shively JE
    J Nucl Med; 2014 Jul; 55(7):1178-84. PubMed ID: 24854793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution and catabolism of (18)F-labeled neurotensin(8-13) analogs.
    Bergmann R; Scheunemann M; Heichert C; Mäding P; Wittrisch H; Kretzschmar M; Rodig H; Tourwé D; Iterbeke K; Chavatte K; Zips D; Reubi JC; Johannsen B
    Nucl Med Biol; 2002 Jan; 29(1):61-72. PubMed ID: 11786277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silicon-Containing Neurotensin Analogues as Radiopharmaceuticals for NTS
    Fanelli R; Chastel A; Previti S; Hindié E; Vimont D; Zanotti-Fregonara P; Fernandez P; Garrigue P; Lamare F; Schollhammer R; Balasse L; Guillet B; Rémond E; Morgat C; Cavelier F
    Bioconjug Chem; 2020 Oct; 31(10):2339-2349. PubMed ID: 32887526
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Wu W; Yu F; Zhang P; Bu T; Fu J; Ai S; You Q; Shi L; Shao G; Wang F; Hodolic M; Guo H
    J Nucl Med; 2022 Sep; 63(9):1394-1400. PubMed ID: 35177423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syntheses, receptor bindings, in vitro and in vivo stabilities and biodistributions of DOTA-neurotensin(8-13) derivatives containing β-amino acid residues - a lesson about the importance of animal experiments.
    Sparr C; Purkayastha N; Yoshinari T; Seebach D; Maschauer S; Prante O; Hübner H; Gmeiner P; Kolesinska B; Cescato R; Waser B; Reubi JC
    Chem Biodivers; 2013 Dec; 10(12):2101-21. PubMed ID: 24327436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiolabeled B9958 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography: Effect of the Radiolabel-Chelator Complex on Biodistribution and Tumor Uptake.
    Zhang Z; Amouroux G; Pan J; Jenni S; Zeisler J; Zhang C; Liu Z; Perrin DM; Bénard F; Lin KS
    Mol Pharm; 2016 Aug; 13(8):2823-32. PubMed ID: 27348517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Evaluation of NHS-Activated Gold Nanoparticles Functionalized with Bombesin or Neurotensin-Like Peptides for Targeting Colon and Prostate Tumours.
    Chilug LE; Niculae D; Leonte RA; Nan A; Turcu R; Mustaciosu C; Serban RM; Lavric V; Manda G
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32722221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors.
    Alshoukr F; Rosant C; Maes V; Abdelhak J; Raguin O; Burg S; Sarda L; Barbet J; Tourwé D; Pelaprat D; Gruaz-Guyon A
    Bioconjug Chem; 2009 Aug; 20(8):1602-10. PubMed ID: 19610615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
    Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M
    J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
    de Visser M; Janssen PJ; Srinivasan A; Reubi JC; Waser B; Erion JL; Schmidt MA; Krenning EP; de Jong M
    Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1134-9. PubMed ID: 12768332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of [
    Wang M; Zhang H; Wang H; Feng H; Deng H; Wu Z; Lu H; Li Z
    Mol Pharm; 2018 Aug; 15(8):3093-3100. PubMed ID: 29889537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of a (18)F-labeled diarylpyrazole glycoconjugate for the imaging of NTS1-positive tumors.
    Lang C; Maschauer S; Hübner H; Gmeiner P; Prante O
    J Med Chem; 2013 Nov; 56(22):9361-5. PubMed ID: 24160350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of
    Marenco M; Lodola L; Persico MG; Frangipane V; Facoetti A; Aprile C; Hodolič M
    Curr Pharm Biotechnol; 2018; 19(9):754-759. PubMed ID: 30160211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Neurotensin-Derived
    Schindler L; Moosbauer J; Schmidt D; Spruss T; Grätz L; Lüdeke S; Hofheinz F; Meister S; Echtenacher B; Bernhardt G; Pietzsch J; Hellwig D; Keller M
    Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Evaluation of 64Cu-DOTA-NT-Cy5.5 as a Dual-Modality PET/Fluorescence Probe to Image Neurotensin Receptor-Positive Tumor.
    Deng H; Wang H; Wang M; Li Z; Wu Z
    Mol Pharm; 2015 Aug; 12(8):3054-61. PubMed ID: 26162008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vivo Evaluation of ¹⁸F-SiFAlin-Modified TATE: A Potential Challenge for ⁶⁸Ga-DOTATATE, the Clinical Gold Standard for Somatostatin Receptor Imaging with PET.
    Niedermoser S; Chin J; Wängler C; Kostikov A; Bernard-Gauthier V; Vogler N; Soucy JP; McEwan AJ; Schirrmacher R; Wängler B
    J Nucl Med; 2015 Jul; 56(7):1100-5. PubMed ID: 25977461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.